|

Self-sampling for Non-attenders to Cervical Cancer Screening

RECRUITINGN/ASponsored by The Institute of Molecular and Translational Medicine, Czech Republic
Actively Recruiting
PhaseN/A
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
Started2019-09-23
Est. completion2025-12-01
Eligibility
Age30 Years – 65 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04226313

Summary

The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.

Eligibility

Age: 30 Years – 65 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women with age 30-65 years; for arm A women \> 65 years are allowed
* Women live in the Czech Republic.
* Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C).
* Women with completed informed consent.
* Women capable of self-sampling of cervicovaginal swab.

Exclusion Criteria:

* Pregnant women.
* Women with no sexual intercourse experience.
* Women after hysterectomy including cervix.

Conditions4

CancerCervical CancerCervical DysplasiaHuman Papillomavirus Infection

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.